Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update [Internet].

Sanders GD, Coeytaux R, Dolor RJ, Hasselblad V, Patel UD, Powers B, Yancy WS Jr, Gray RN, Irvine RJ, Kendrick A.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun.

2.

Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.

Powers BJ, Coeytaux RR, Dolor RJ, Hasselblad V, Patel UD, Yancy WS Jr, Gray RN, Irvine RJ, Kendrick AS, Sanders GD.

J Gen Intern Med. 2012 Jun;27(6):716-29. doi: 10.1007/s11606-011-1938-8. Epub 2011 Dec 7. Review.

5.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.

PMID:
17984484
6.

Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.

Zou Z, Yuan HB, Yang B, Xu F, Chen XY, Liu GJ, Shi XY.

Cochrane Database Syst Rev. 2016 Jan 27;(1):CD009210. doi: 10.1002/14651858.CD009210.pub2. Review.

PMID:
26816003
7.

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

Li EC, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2014 Aug 22;(8):CD009096. doi: 10.1002/14651858.CD009096.pub2. Review.

PMID:
25148386
8.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.

Zhang L, Zeng X, Fu P, Wu HM.

Cochrane Database Syst Rev. 2014 Jun 23;(6):CD009120. doi: 10.1002/14651858.CD009120.pub2. Review.

PMID:
24953826
9.

Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.

Driscoll A, Currey J, Tonkin A, Krum H.

Cochrane Database Syst Rev. 2015 Dec 21;(12):CD009889. doi: 10.1002/14651858.CD009889.pub2. Review.

PMID:
26689943
10.

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.

Cochrane Database Syst Rev. 2015 Jan 11;1:CD008170. doi: 10.1002/14651858.CD008170.pub2. Review.

PMID:
25577154
11.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Review.

PMID:
24488616
12.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974. Review.

PMID:
25236305
13.

Cochrane in context: pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.

Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975. Review.

PMID:
25236306
14.

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.

Musini VM, Nazer M, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2014 May 29;(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Review.

PMID:
24869750
15.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

16.

Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.

Shahin Y, Khan JA, Samuel N, Chetter I.

Atherosclerosis. 2011 May;216(1):7-16. doi: 10.1016/j.atherosclerosis.2011.02.044. Epub 2011 Feb 26. Review.

PMID:
21411098
17.

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi P, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

18.

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy.

Neutel JM.

Curr Med Res Opin. 2010 Jan;26(1):213-22. doi: 10.1185/03007990903444434. Review.

PMID:
19921961
20.

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

Al Khalaf MM, Thalib L, Doi SA.

Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.

PMID:
19178130
Items per page

Supplemental Content

Write to the Help Desk